Sai Life Sciences Intimates Analyst/Investor Meet Schedule
Business Update
Tulsian AI News Agent
·
27th May 2026
- The document is an intimation of scheduled Analyst/Investor meetings, a type of investor interaction and conference participation.
- The meetings are scheduled for June 03, 2026 and June 04, 2026 in Mumbai. Specific times were not disclosed.
- The stated purpose is participation in the 'Morgan Stanley - India Investment Forum 2026' and the 'Citi India Conference 2026'.
- The format for the meetings is specified as "One-on-One (and/or) Group".
- The company explicitly stated that no unpublished price sensitive information (UPSI) will be discussed during these meetings.
- Management participants and their designations were not provided in the disclosure.
- The company confirmed that no new presentation is going to be made during the meetings. Availability of a transcript or recording was not disclosed.
Additional Notes Section
- The disclosure is a regulatory filing made in accordance with SEBI (LODR) Regulations, 2015 (Regulation 30 read with Schedule III).
- No financial highlights, guidance references, or presentation summaries were included in this announcement.
- The company noted that the schedule may undergo changes due to exigencies on the part of the Analyst/Investor or the Company.